Skip to main content

Published locations for HER2-negative gastric cancer: Docetaxel-based chemotherapy does not improve outcomes

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. HER2-negative gastric cancer: Docetaxel-based chemotherapy does not improve outcomes

User login

  • Reset your password
  • /content/her2-negative-gastric-cancer-docetaxel-based-chemotherapy-does-not-improve-outcomes
  • /hematology-oncology/article/254102/gastrointestinal-cancer/her2-negative-gastric-cancer-docetaxel